BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy.
| Image |  |
|---|---|
| Description | scientific article published on 8 March 2018 |
| Author/s |
author: Kai Rothkamm Wael Y Mansour Christoph Oing Carsten Bokemeyer |
| Publication date | March 8, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |